Key facts
- It has raised $3.3M across 1 recorded rounds; the latest was Seed Round ($3.3M) in Feb 2025.
- Notable investors include US National Science Foundation, Spark Capital, Service Provider Capital, Michigan Rise, Douglas Song — 10 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for CircNova
Funding rounds
1 roundsAbout CircNova
Operator of a biotechnology company intended to focus on non-coding RNA with many mechanisms of action against undruggable disease targets. The company uses artificial intelligence to generate, analyze, and identify circular RNA for therapeutic development, enabling biopharmaceutical companies to develop treatments for undruggable diseases, improve patient outcomes, and address major unmet clinical needs.
- Industry
- Biotechnology
- Sector
- Healthcare
- HQ
- Detroit, MI, United States
- Founded
- 2023
- Employees
- 9
- Website
- circnova.com/
- Ownership
- Privately Held (backing)
CircNova doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CircNova shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CircNova in its N-PORT filings yet. We sweep new filings monthly.